Press release
Investigation announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK)
An investigation for investors in DermTech, Inc. (NASDAQ: DMTK) shares over potential securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of DermTech, Inc. (NASDAQ: DMTK) concerning whether a series of statements by DermTech, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
San Diego, CA based DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to aid in the diagnosis and management of various skin conditions, including skin cancer and inflammatory diseases in the United States. DermTech, Inc. reported that its annual Total Revenue rose from $11.83 million in 2021 to $14.51 million in 2022, and that its Net Loss increased from $78.33 million in 2021 to $116.68 million in 2022.
Shares of DermTech, Inc. (NASDAQ: DMTK) declined from over $84 per share in February 2021 to as low as $1.55 per share in late December 2022.
On April 11, 2023, NASDAQ: DMTK shares closed at $3.68 per share.
Those who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for Investors who lost money with shares of DermTech, Inc. (NASDAQ: DMTK) here
News-ID: 3008716 • Views: …
More Releases from Shareholders Foundation
Biohaven Ltd. (NYSE: BHVN) Investor Alert: Deadline in Lawsuit on September 12, …
A deadline is coming up on September 12, 2025in the lawsuit filed for certain investors of Biohaven Ltd. (NYSE: BHVN) over alleged securities laws violations by Biohaven Ltd.
Investors who purchased shares of Biohaven Ltd. (NYSE: BHVN) have certain options and there are strict and short deadlines running. Deadline: September 12, 2025. NYSE: BHVN stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
More Releases for DermTech
Investigation over potential Wrongdoing announced for Investors who lost money w …
An investigation was announced for long-term investors in shares of DermTech, Inc. (NASDAQ: DMTK) concerning potential breaches of fiduciary duties by certain directors and officers of DermTech, Inc.
Investors who are current long term investors in DermTech, Inc. (NASDAQ: DMTK) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ:…
Europe Skin Cancer Diagnostics Market Trends & Outlook 2032
Based on Inkwood's report, the Europe Skin Cancer Diagnostics Market, encompassing countries such as Germany, Spain, France, Belgium, Poland, Italy, Nordic Countries, the United Kingdom, and the Rest of Europe, is poised for significant growth with a projected Compound Annual Growth Rate (CAGR) of 6.72% in revenue during the forecast period from 2023 to 2032.
Refer to the Report Summary Here: https://inkwoodresearch.com/reports/europe-skin-cancer-diagnostics-market/?utm_source=PaidPRNew&utm_medium=OpenPR&utm_campaign=InkwoodPR
Leading the charge in this market are major companies…
Deadline on Dec. 15th coming up in Lawsuit for Investors in DermTech, Inc. (NASD …
A deadline is coming up on December 15, 2023 in the lawsuit filed for certain investors of DermTech, Inc. (NASDAQ: DMTK) over alleged securities laws violations by DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and there are strict and short deadlines running. Deadline: December 15, 2023. NASDAQ: DMTK stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the…
Cancer Cell Biopsy Service Market Demand Will Increase to 2029 Evaluated By Glob …
The market report delivers an all-inclusive analysis of the market structure along with a forecast of the various segments and sub-segments of the Cancer Cell Biopsy Service industry. This wide-ranging market research report acts as a backbone for the success of business in any niche. The Cancer Cell Biopsy Service market survey report has been prepared by conducting market research in a systematic manner. Moreover, the Cancer Cell Biopsy Service…
Lawsuit filed for certain Investors who lost money with shares of DermTech, Inc. …
An investor, who purchased shares of DermTech, Inc. (NASDAQ: DMTK), filed a lawsuit over alleged violations of Federal Securities Laws by DermTech, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2023. NASDAQ:…
Investigation announced for Investors in shares of DermTech, Inc. (NASDAQ: DMTK) …
An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at DermTech, Inc.
Investors who purchased shares of DermTech, Inc. (NASDAQ: DMTK) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain DermTech directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Diego, CA based DermTech,…
